Filing Details

Accession Number:
0001209191-10-018448
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-03-23 13:00:00
Reporting Period:
2010-03-22
Filing Date:
2010-03-23
Accepted Time:
2010-03-23 21:06:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1087432 Intermune Inc ITMN Pharmaceutical Preparations (2834) 943296648
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1306194 Iii Z Williamson Bradford 3280 Bayshore Boulevard
Brisbane CA 94005
Svp-Clinical Science No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-03-22 5,626 $10.11 5,625 No 4 M Direct
Common Stock Disposition 2010-03-22 5,626 $40.69 0 No 4 S Direct
Common Stock Acquisiton 2010-03-22 24,374 $10.11 24,374 No 4 M Direct
Common Stock Disposition 2010-03-22 24,374 $40.69 28,290 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Incentive Stock Optiom (Right to buy) Disposition 2010-03-22 5,626 $0.00 5,626 $10.11
Common Stock Non-Qualified Stock Optiom (Right to buy) Disposition 2010-03-22 24,374 $0.00 24,374 $10.11
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2008-09-10 2014-09-10 No 4 M Direct
0 2005-09-10 2014-09-10 No 4 M Direct